Abstract Purpose: To formulate an optimized gastric floating drug delivery system (GFDDS) containing glipizide with carbomers and cellulosic polymers.
INTRODUCTION
The challenge in developing controlled release system is not only in sustaining the release but also to prolong the retention of dosage form in the stomach or the upper small intestine until all the drug is completely released in the desired time period [1, 2] . Approaches proposed to control the gastric residence of delivery systems in the upper gastrointestinal tract (GIT) include floating drug delivery systems (FDDS) [3] [4] [5] , high-density [6, 7] , mucoadhesive [8, 9] , swelling and expanding [10] , modified shape and other delayed gastric devices [2, 11, 12] .
A minimum growth of 9% per year had been proposed for this market since 2003 [13] , as these offers several advantages, including improved patient compliance, better therapeutic efficiency, potential for patentability, and extending the product life-cycle. Extendedrelease stomach retentive dosage forms are also desirable for drugs with a narrow absorption window, stability and solubility problems in the intestinal or colonic environment, and drugs that are locally acting in the stomach [3] . A major drawback for this delivery device is that it cannot be employed in the formulation of drugs which cannot be well absorbed throughout the GIT [14] [15] [16] . Glipizide is an anti-diabetic drug [17] which is effective in the management of type-II diabetes mellitus. The recommended adult dose is 5 mg twice daily (or) 10 mg once daily. Absorption is in the stomach, and short biological half-life (ranging from 3.5 to 4 h) following oral administration, Further, its short half-life (3.5 h), low dose (5 -20 mg), narrow absorption window (stomach), high physico-chemical stability etc. make glipizide an ideal drug for floating matrix formulation [18] . These gastro-retentive systems continuously release the drug before it reaches the absorption window, thus ensuring optimal bioavailability [19] .
EXPERIMENTAL Materials
Glipizide was obtained as gift sample from USV Ltd (India). HPMC K4M, (ZydusCadila, India), CP934P (Noveon, India), sodium bicarbonate (Merck, Germany) magnesium stearate, talc and microcrystalline cellulose (SD Fine, India) were also used in the study. All other chemicals used were of analytical grade and used as received. Double distilled water was used in the study.
Central composite design (CCD)
CCD with α = 1 was employed as per the standard protocol. In the study independent variables were concentration of HPMC K4M (A) and CP934P (B) and dependent variables included total floating time (TFT), floating lag time (FLT), and time for 50% release (T 50 ). Tables 1 summarize an account of the all experimental runs, coded and actual levels of independent variables.
Preparation of floating tablets
Tablets were formulated using HPMC K4M and CP934P polymers for floating and release rate control. Sodium bicarbonate was added as a gas-generating agent (CO 2 ) in the presence of gastric fluid. Glipizide was mixed with the required quantities of HPMC K4M, CP 934P and Sodium bicarbonate by geometric mixing then mixture was blended with microcrystalline cellulose (q.s. 200 mg), magnesium stearate 1 % and talc 2 %, and further mixed for additional 2-3 min. Then 200 mg tablets containing 10 mg glipizide were prepared by direct compression Minipress-I, 16 station rotatory tableting machine (Rimek Karnawati, India) using 8-mm flat face punch. Compression force was adjusted for hardness in the range of 3.5 -4.5 kg/cm 2 . The batches of 25 tablets were prepared for each batch of all the experimental runs ( Table 1) . Microcrystalline cellulose was used as a filler to adjust each tablet weight to 200 mg because it does not interfere with the floating property of the tablet due to its low bulk density [21] .
In-vitro buoyancy studies
Buoyancy studies were done to determine FLT and TFT according to the method described by Rosa et al [22] . The tablets were placed in a 100 ml beaker containing 0.1 mol/L of HCl. The time required for the tablet to rise to the surface and float was taken as the FLT and TFT, the time during which tablet remains buoyant was recorded.
In-vitro swelling ability
Single tablet was weighed (W 1 ) and placed in a glass beaker with 200 ml of 0.1N HCl, and maintained in a water bath at 37.0 ± 0.5 0 C. At regular time intervals, the tablet was removed from beaker and the excess surface liquid was carefully removed with filter paper. The swollen tablet was weighed again (W 2 ) [23] .
The swelling index (SI) was calculated using Eq 1.
In-vitro dissolution studies
The release rate of glipizide from floating matrix tablets (n = 6) was determined according to USP XXIV using type II apparatus (Electrolab, TDT-08L, India). The dissolution test was performed using 900 mL of 0.1mol L -1 HCl at 37 ± 0.5 °C and 50 rpm [24] . Samples (5 mL) were withdrawn from the dissolution apparatus and replaced with fresh medium. The samples were filtered through a 0.45 µm membrane and diluted to a suitable concentration with 0.1 mols L -1 HCl. Absorbance of samples were measured at 274 nm (Shimadzu UV-1800, Japan) [25] and Cumulative drug release was calculated. The FLT and TFT of the tablets were measured during dissolution studies.
Statistical analysis and optimization data
Drug release data were analyzed using ZOREL software [26] which have in-built provisions for applying the correction factor for volume and drug losses during sampling [27] .
Based on phenomenological analysis, the type of release was predicted, i.e., whether Fickian, nonFickian or zero-order. The value of T 50 was calculated using Stineman interpolation option of the Graph 2.0 software (M/s Micromath Inc., Saint Louis, USA).
Drug release data were subjected to various release models, including Higuchi model (Eq 2), which indicates whether the drug release mechanism deviates from Fick's laws and shows anomalous behaviour [28] .
where, Q is the amount of drug release at time t, and K H is the Higuchi rate constant.
The dissolution data was also fitted to Koresmeyer model which is used to describe drug release behaviour from polymer systems (Eqs 3 and 4) [29] .
Log (Mt/Mα) = log K+ n Log t …………….. (4) where 'Mt' is the amount of the drug release at time 't', 'Mα' is the amount of drug release after infinite time and 'K' is a release rate constant incorporating structural and geometric characteristic of the tablet and 'n' is the diffusion exponent indications for release mechanism.
For the studied design, the multiple linear regression analysis (MLRA) method was applied using Design Expert 6.0.6 (Stat-Ease, Minneapolis, USA) software to fit full second order polynomial equation (Eq 4) with added interaction terms to correlate the studied responses with the examined variables.
The polynomial regression results were demonstrated for the studied responses. Finally, the prognosis of optimum formulation was conducted using a two-stage brute force technique using MS-Excel spread sheet software. First, a feasible space was located and second, an exhaustive grid search was conducted to predict the possible solutions. Four formulations were selected as the confirmatory check-points to validate by response surface methodology (RSM). The observed and predicted responses were critically compared. Linear correlation plots were constructed for the chosen four optimized formulations, and the percent bias (prediction error) was calculated with respect to the observed responses.
RESULTS
Oral floating controlled drug delivery of glipizide was developed and optimized using mixture of HPMC K4M and CP934P which were found suitable for obtaining directly compressible matrix tablet with suitable technological properties and well reproducible drug release profiles. For optimization, preliminary trials were carried out using different concentrations of HPMC K4M and CP934P to shortlist the levels.
Drug content and physical evaluation
The physical parameters of the compressed tablets were found within the specifications. As the assayed drug content in formulations ranges between 98.2% and 102.7%, weight variation between 198.22 mg and 201.1 mg. Hardness also has an effect on the floating and disintegration thus dissolution, it was ranging between 4.05 to 4.5 kg/cm 2 . Friability of all batches was between 0.44 %w/w to 0.86 %w/w i.e. less than the limit of 1%w/w. The swelling index results of all batches were found between 0.45-0.82 up to 6 h. All these results are shown in Table 2 .
Tablet floating behaviour
TFT for all formulation ranged from 9.28 -20.65 h while FLT of all formulations was within the range 5.2 -34.2 s (Table 2) . Table 3 shows the various the dissolution parameters for the matrix formulations.
Drug release
The drug release data shows that the values of release rate exponent (n), ranged between 0.4642 and 0.4841 drug released from all the formulations up to 12 h ranged between 83.69 and 88.8 % and it is clear from the results that the release tended to decrease with increase in (Table 3) .
DISCUSSION
Tablets (gel-forming matrices) possessing sufficient structure to form a gel layer and they achieve an overall specific gravity lower than that of gastric fluid. TFT of the tablets increased with increase in HPMC K4M content, owing ostensibly to swelling (i.e., hydration) of the hydrocolloid particles on the tablet surface, resulting ultimately in an increase in the bulk volume. The air formed because of bicarbonate and hydrochloric acid entrapped in the swollen polymer matrix and it results in a density less than unity which ultimately results in imparting buoyancy to the tablets [30] . TFT decreases with an increase in CP934P content because of its higher density (1.76 g/cc) when compared to that of HPMC (1.28 g/cc).
Values of "n" indicate non-Fickian release behaviour for all formulations. The result also shows that with increase in the amount of either polymer the values of k declines. Comparatively much higher magnitude of k 1 vis-à-vis k 2 clearly shows that the drug release was predominantly Fickian diffusion, with a very little contribution of polymer relaxation. As viscosity of the gel layer around the tablet increased with an increase in the hydrogel concentration, it decreases the release of drug [31, 32] . The gel formed during the penetration of dissolution medium into the matrix consisted of closely packed swollen particles, with more polymer amount, more thick gel formed inhibits dissolution medium penetration more strongly, and resulting in a reduction in the drug release values in 12 h indicating slower drug release. Therefore the values of T 50 enhanced markedly from 4.09 h, observed at low levels of both the variables, to as high as 4.82 h, observed at high levels of both the variables, which shows considerable release retarding potential of the polymer. T 50 shows that at high concentration of polymers the drug release slows besides having initial burst effect.
Various mathematical relationships were generated using MLRA for the studied response variables. High values of R 2 of the MLRA coefficients for all three responses, ranging between 0.9946 and 0.9999, vouch high prognostic ability of the RSM polynomials. where A and B are independent variables representing the amounts of HPMC K4M and CP934P in the formulation. Figure 1 portray the 3-dimensional response surface plots for the studied response properties, viz., T 50 , FLT, and TFT along with the corresponding 2-dimensional contour plots. T 50 shows a linear trend in the values of T 50 , markedly increasing with the increment of HPMC K4M levels while With CP934P, the values of T 50 tend to increase almost linearly but to a slower extent where at the higher level of CP934P this linear increase in T 50 vanishes. The same is evident from the corresponding contour plot, showing somewhat inclining linear contour lines, while combination of both shows almost synergistic effect on T 50 by them. FLT shows a nearly linear ascending pattern for the values of FLT, as the content of HPMC K4M polymer is decreased, the effect being reverse and less prominent with CP934P decrease than with HPMC K4M.
TFT portrays a linear relationship of TFT with increasing amounts of HPMC K4M and CP934P. At low HPMC K4M levels, the value of TFT is less and it increases linearly with an increase in HPMC K4M. On the other hand, the value of TFT at low levels of CP934P is more and with increasing amount of CP934P it decreases; the same is shown by the contour plot for TFT.
The increase in T 50 with HPMC K4M was due to its higher hydrophillic ability. Furthermore, the gel layer formed was more viscous resulting to a greater retard in drug release when compared with CP934P.
It was observed that FLT for all tablets was below 35 s regardless of the content of various polymers used, it indicates there is a significant effect of the concentration of polymers (Table 1) . Evolution and entrapment of carbon dioxide inside the hydrated polymeric matrices, resulted from the interaction between the gas generating agent (NaHCO 3 ) and dissolution medium (0.1 mol L -1 HCl, pH 1.2). This was responsible for the lowering of the density of matrices enabling the tablets to float. From the results of multiple regression analysis, it was found that the dependent variables, T 50 , FLT and TFT are strongly dependent on the independent variables ( Figure 1 , Table 4 ). The correlation coefficients indicate a good fit in the T50%, FLT and TFT linear plots. Polynomial equations (Eq. 5-7) can be used to draw a conclusion after considering . As the amount of CP934P increased, TFT decreased; this may be due to high affinity of CP934P toward water, which promotes water penetration into tablet matrices, leading to increased density. As the amount of HPMC K4M increased, TFT increased; this is because of increased gel strength of matrices, which prevents escape of evolved carbon dioxide from matrices, leading to decreased density. As the amount of HPMC K4M and CP934P increased, T 50 decreased; this may be due again to high affinity of HPMC K4M and CP934P toward water, which promotes water penetration into tablet matrices, leading to solubilisation of glipizide.
Selection of optimum formulation and DoE validation
For selecting optimum formulation, the responses observed (experimental) were compared with the expected ones (predicted), (Figure 1 , Table 1 ), indicating excellent goodness of fit (p < 0.05). The optimum formulation was selected by trading off various response variables and adopting the following maximizing criteria: T 50 >4 h; TFT>12 h and FLT<15 s. Upon comprehensive evaluation of grid searches, the formulation (HPMC: 47.32 mg and CP934P: 8.4 mg) fulfilled the optimal criteria of best regulation of the release rate T 50 = 4.5 h; TFT=15.06 h and FLT=11.41 s, this formulation was taken as optimized formulation.
CONCLUSION
The task of attaining and balancing the required floatation and drug release profile was achieved in the present study using appropriate DoE i.e. CCD with blends of polymers like carbomers and methylcelluloses because of the diverse nature of these polymers. Carbomers, have higher density than the celluloses They are also considered unsuitable to impart buoyancy but useful for controlling drug release while lighter hydrophilic methylcelluloses impart floatation and also influence drug release. Hence, the present work can be considered a platform technology in the manufacture of gastroretentive floating formulations of glipizide.
